Prior adherence to recommended lipid control targets in patients admitted for acute coronary syndrome

Laia Milà1, José A Barrabés1, Rosa-Maria Lidón1

  • 1Unidad Coronaria, Servicio de Cardiología, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, CIBERCV, Barcelona, Spain.

Insights

Optimal lipid control remains a challenge for acute coronary syndrome patients. Only 34.2% achieved recommended low-density lipoprotein-cholesterol (LDL-C) targets, highlighting a need for improved cardiovascular risk management.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Preventive Medicine

Background:

  • Optimal lipid control is crucial but difficult to achieve.
  • European Society of Cardiology (ESC) guidelines set targets for low-density lipoprotein-cholesterol (LDL-C).
  • Acute coronary syndrome (ACS) patients often have high cardiovascular risk.

Purpose of the Study:

  • To assess pre-admission LDL-C control in patients hospitalized for ACS.
  • To determine the frequency of achieving ESC targets for LDL-C.
  • To identify predictors of inadequate lipid control in this population.

Main Methods:

  • Fasting LDL-C levels were measured in 3164 ACS patients (2010-2017).
  • Adequate LDL-C control was defined by individual cardiovascular risk.
  • Statistical analysis identified predictors of inadequate and adequate control.

Main Results:

  • Median LDL-C was 104 mg/dL; only 34.2% met recommended targets.
  • Adequate LDL-C control increased moderately over the study period.
  • Inadequate control was linked to higher patient risk, dyslipidemia, smoking, diabetes, and BMI ≥ 25. Statin therapy correlated with adequate control.

Conclusions:

  • Slightly over one-third of ACS patients achieve LDL-C goals upon admission.
  • Significant opportunities exist for improving primary and secondary prevention strategies.
  • Overweight patients and those with multiple risk factors require intensified lipid management.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
191
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
286
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
554
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
230
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
205
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K